Solazyme Inc. (SZYM) Drops 5.68% on January 15

Equities Staff |

Solazyme Inc. (SZYM) was one of the Russell 2000's biggest losers for Friday January 15 as the stock slid 5.68% to $1.66, a loss of $-0.1 per share. Starting at an opening price of $1.61 a share, the stock traded between $1.58 and $1.73 over the course of the trading day. Volume was 501,351 shares over 1,646 trades, against an average daily volume of 532,471 shares and a total float of 80.54 million.

The losses send Solazyme Inc. down to a market cap of $133.69 million. In the last year, Solazyme Inc. has traded between $4.74 and $1.65, and its 50-day SMA is currently $2.73 and 200-day SMA is $2.96.

Solazyme Inc, along with its subsidiaries, is engaged in providing renewable oils and other bioproducts. It commercializes its products into target markets such as chemicals and fuels, nutrition, and skin and personal care.

Solazyme Inc. is based out of South San Francisco, CA and has some 266 employees. Its CEO is Jonathan S. Wolfson.

For a complete fundamental analysis analysis of Solazyme Inc., check out Equities.com’s Stock Valuation Analysis report for SZYM. To see the latest independent stock recommendations from Equities.com’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Equities.com. Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Comments

Emerging Growth

Altair Resources Inc.

Altair Resources Inc, formerly Altair Gold Inc acquires, explores and develops mineral properties in Canada. The Company is in the process of exploring its mineral properties.

Private Markets

BioSculpture Technology, Inc.

BioSculpture Technology, Inc. (“BST”) is a commercial-stage medical device manufacturer of liposuction surgical instruments for surgeons. It offers the FDA-cleared Twin Cannula Assisted Liposuction ("TCAL") Airbrush Liposculptor II® controllers, Airbrush®…

WayBetter

The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…